Legend Earnings per Diluted Share from 2010 to 2023
| LEGN Stock | USD 67.17 0.14 0.21% |
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Cost of Revenue of 58.5 M, Gross Profit of 62.4 M or Interest Expense of 11.6 M, as well as many exotic indicators such as Asset Turnover of 0.1, Book Value per Share of 4.09 or Current Ratio of 3.7. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules.
Legend | Earnings per Diluted Share |
Legend Earnings per Diluted Share Breakdown
Showing smoothed Earnings per Diluted Share of Legend BiotechCorp with missing and latest data points interpolated. Earnings per diluted share as calculated and reported by the company. Approximates to the amount of Net Income Common Stock for the period per each [SharesWADil] after adjusting for [ShareFactor].. Legend BiotechCorp's Earnings per Diluted Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (3.16) X | 10 Years Trend |
|
Earnings per Diluted Share |
| Timeline |
Legend Earnings per Diluted Share Regression Statistics
| Arithmetic Mean | (0.87) | |
| Geometric Mean | 0.11 | |
| Coefficient Of Variation | (145.75) | |
| Mean Deviation | 1.09 | |
| Median | (0.02) | |
| Standard Deviation | 1.26 | |
| Sample Variance | 1.60 | |
| Range | 3.00 | |
| R-Value | (0.84) | |
| Mean Square Error | 0.50 | |
| R-Squared | 0.71 | |
| Significance | 0.00015517 | |
| Slope | (0.25) | |
| Total Sum of Squares | 20.77 |
Legend Earnings per Diluted Share History
About Legend BiotechCorp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Earnings per Diluted Share, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for 2023 | ||
| Earnings per Diluted Share | (2.80) | (3.02) | |
| Earnings Before Interest Taxes and Depreciation Amortization EBITDA | -416.5 M | -427.5 M | |
| Earnings before Tax | -445.7 M | -457.5 M |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.16) | Revenue Per Share 0.986 | Quarterly Revenue Growth 5.126 | Return On Assets (0.21) | Return On Equity (0.54) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.